We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fructose Intolerance Is Common in Children with Abdominal Pain

By LabMedica International staff writers
Posted on 02 Nov 2010
Fructose malabsorption or fructose intolerance is common in children with recurrent or functional abdominal pain.

Fructose intolerance is typically diagnosed by exclusion that once other gastro-intestinal conditions like Crohn's disease and ulcerative colitis are ruled out, a hydrogen breath test is given to the patient. More...
If the patient's breath hydrogen exceeds 20 ppm points above baseline, then the patient is likely to be fructose intolerant.

Scientists at the Mary Bridge Children's Hospital, (Tacoma, WA, USA), investigated a total of 245 patients with unexplained chronic abdominal pain alone or associated with constipation, gas or bloating and/or diarrhea. The ages ranged from 2 to 18 years old, with a median age of 11 and 62.1% were female. The patients received a standard dose of fructose (1 g/kg, to a maximum of 25 g), followed by a breath hydrogen test (BHT), which measured methane levels at 30-minute intervals for 90 minutes. The test for fructose was performed in all patients in the study and it was positive for fructose intolerance in 132 of 245 patients (53.9 %). A total of 113 of 245 (46.1%) of patients had a negative BHT for fructose intolerance. All of the 132 patients with a positive BHT for fructose had a nutritional consult with a registered dietician and were placed on a low-fructose diet. Using a standard pain scale for children, 88 of the 132 patients (67.7%) reported resolution of symptoms on a low-fructose diet.

Daniel Lustig, M.D., a pediatric gastroenterologist at the hospital, said, "Fructose intolerance is more prevalent in teenage girls with chronic abdominal pain. While there is definitely a subset of patients who respond well to a low-fructose diet, it is challenging for patients who are fructose intolerant to maintain, especially teenagers. But the good news is that over half of patients who are fructose intolerant are able to maintain a low-fructose diet and are able to notice an immediate improvement in their symptoms.” The results of the study were unveiled at the American College of Gastroenterology's 75th Annual Scientific meeting, October 15 - 20, 2010, in San Antonio, TX, USA.

Related Links:
Mary Bridge Children's Hospital




New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
HPV Molecular Test
BD Onclarity HPV Assay
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.